Symonds Jonathan 4
4 · Rubius Therapeutics, Inc. · Filed May 13, 2022
Insider Transaction Report
Form 4
Symonds Jonathan
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-12+25,000→ 25,000 totalExercise: $1.24Exp: 2032-05-11→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This option shall vest in full on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the recipient's continued service.